Impact of an Interdisciplinary Integrative Group-Based Program for Patients with Cancer: Prospective, Nonrandomized Intervention Study with a Waiting-List Control
Current Oncology · 2026
DOI: 10.3390/curroncol33010044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2026. Verfasst von Burcu Babadağ Savaş und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Hannover Medical School, 30625 Hannover, Germany. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The foundations Rut und Klaus Bahlsen Stiftung and the Förderstiftung MHH plus, foundations Rut und Klaus Bahlsen Stiftung, Förderstiftung MHH plus.
Abstract (Originalsprache)
Background/Objectives: Cancer is a disease with a rising global incidence each year, and an interdisciplinary approach for both its treatment and care is needed. This study aimed to evaluate the effects of a 10-week interdisciplinary integrative oncology group-based program for patients with cancer on quality of life, fatigue, resilience, well-being, anxiety and depression.
Methods
This prospective, nonrandomized intervention, waiting-list control group study evaluated the quality of life, fatigue, resilience, anxiety, depression and well-being of a total of 128 patients with cancer (intervention group: n = 86; waiting-list control group: n = 42) at baseline (week 0) and at the end of the observation period (week 10).
Results
Compared with patients in the waiting-list group, patients who participated in a 10-week interdisciplinary integrative group program during or after cancer treatment had positive effects on quality of life, social/family well-being, functional well-being, resilience, fatigue, and anxiety. Specifically, significant time × group effects were observed on (FACT-G: p = 0.002, η2 = 0.73; FACIT-Fatigue: p = 0.014, η2 = 0.47; FACIT-F: p = 0.002, η2 = 0.74), social/family well-being (p = 0.015, η2 = 0.46), functional well-being (p < 0.001, η2 = 0.102), with a large effect size and resilience mean scores (p = 0.003, η2 = 0.069), and anxiety mean scores (p = 0.005, η2 = 0.060), with a medium effect size.
Conclusions
This study revealed that compared with nonparticipants, participants in the 10-week interdisciplinary program benefited more from the program.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy, Hannover Medical School, 30625 Hannover, Germany.
- Klaus-Bahlsen-Center for Integrative Oncology, Comprehensive Cancer Center Lower Saxony, Hannover Medical School, 30625 Hannover, Germany.
- Institute of Biostatistics, Hannover Medical School, 30625 Hannover, Germany.
ORCID-Profile: Burcu Babadağ Savaş, Diana Steinmann
Förderung
- The foundations Rut und Klaus Bahlsen Stiftung and the Förderstiftung MHH plus
- foundations Rut und Klaus Bahlsen Stiftung
- Förderstiftung MHH plus
Zitieren
APA
Babadağ Savaş, B., Märtens, B., Ziert, Y., & Steinmann, D. (2026). Impact of an Interdisciplinary Integrative Group-Based Program for Patients with Cancer: Prospective, Nonrandomized Intervention Study with a Waiting-List Control. Current Oncology. https://doi.org/10.3390/curroncol33010044
Vancouver
Babadağ Savaş B, Märtens B, Ziert Y, Steinmann D. Impact of an Interdisciplinary Integrative Group-Based Program for Patients with Cancer: Prospective, Nonrandomized Intervention Study with a Waiting-List Control. Current Oncology. 2026. doi:10.3390/curroncol33010044
BibTeX
@article{BabadaSava2026,
author = {Babadağ Savaş, Burcu and Märtens, Bettina and Ziert, Yvonne and Steinmann, Diana},
title = {Impact of an Interdisciplinary Integrative Group-Based Program for Patients with Cancer: Prospective, Nonrandomized Intervention Study with a Waiting-List Control},
journal = {Current Oncology},
year = {2026},
doi = {10.3390/curroncol33010044}
}
EUVIMED